Company profile for OncoQuest

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

OncoQuest Inc. is a clinical development stage biotechnology company which is a subsidiary of Quest Pharmatech (QPT:TSXV), headquartered in Canada, focused on commercializing a portfolio of immuno-modulatory antibodies for the treatment of cancer. These antibodies target a number of tumorigenic proteins, including CA-125, MUC 1, PSA and Her2/neu. Numerous clinical and preclinical studies support the expectation that cancer ...
OncoQuest Inc. is a clinical development stage biotechnology company which is a subsidiary of Quest Pharmatech (QPT:TSXV), headquartered in Canada, focused on commercializing a portfolio of immuno-modulatory antibodies for the treatment of cancer. These antibodies target a number of tumorigenic proteins, including CA-125, MUC 1, PSA and Her2/neu. Numerous clinical and preclinical studies support the expectation that cancer immunotherapies will be most beneficial when utilized as part of combination treatments which may include novel immunotherapies, in addition to well-established approaches such as chemotherapy or radiation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
8123 Roper Road NW Edmonton, Alberta T6E 6S4
Telephone
Telephone
780-448-1400
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/oncoquest-pharmaceuticals-inc-announces-first-patient-enrolled-in-each-of-two-investigator-initiated-clinical-trials-of-oregovomab-in-combination-therapy-for-the-treatment-of-recurrent-ovarian-cancer-301367853.html

PRNEWSWIRE
01 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty